Life sciences investor Catalio Capital Management has been on a fundraising tear since it spun out of private equity firm Camden Partners Holdings slightly more than two years ago. If dealmaking continues to founder in a sputtering economy, Catalio will be well positioned to take advantage of declining valuations.
The pairing of private equity and venture capital firms focused on life sciences seems to provide a win-win, giving PE firms early access to drug discovery and giving VC firms capital and access to the PE firms' LPs.
Space Perspective, a luxury spaceflight experience company, has raised $17 million in funding.
Glean, a unified enterprise search and discovery platform enabling remote work, has raised $100 million in Series C funding, according to a blog post.
Credo AI, a responsible AI governance platform, has raised $12.8 million in Series A funding.
The Professional Fighters League, a sports league, has closed $30 million in Series E funding.
Coins.ph, a Philippines-based fiat and crypto wallet services provider, has raised $30 million in Series C financing.
Locus Biosciences Inc, a clinical-stage biotechnology company, has raised $35 million in funding.
Inceptor Bio, a biotechnology company, has secured $37 million in Series A financing.
Velocity Global, a provider of global talent solutions, has raised $400 million in Series B funding.